0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global General Anesthesia Medicine Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-2R13895
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global General Anesthesia Medicine Market Research Report 2023
BUY CHAPTERS

Global General Anesthesia Medicine Market Research Report 2024

Code: QYRE-Auto-2R13895
Report
July 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

General Anesthesia Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

General Anesthesia Medicine Market

General Anesthesia Medicine Market

General anesthetics are medicines that render a patient reversibly unconscious and unresponsive in order to allow surgeons to operate on that patient.
The global General Anesthesia Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Anesthesia Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthesia Medicine.

Report Scope

The General Anesthesia Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anesthesia Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anesthesia Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of General Anesthesia Medicine Market Report

Report Metric Details
Report Name General Anesthesia Medicine Market
CAGR 5%
Segment by Type
  • Propofol
  • Etomidate
  • Midazolam
  • Sevoflurane
  • Isoflurane
  • Others
Segment by Application
  • Intravenous Anesthetics
  • Inhalational Anesthetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astrazeneca, B.Braun, Fresenius-Kabi, Hikma Pharmaceuticals, Maruishi, Nhwa, Piramal, AbbVie, Baxter Healthcare, Hengrui, Lunan, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of General Anesthesia Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the General Anesthesia Medicine Market report?

Ans: The main players in the General Anesthesia Medicine Market are Astrazeneca, B.Braun, Fresenius-Kabi, Hikma Pharmaceuticals, Maruishi, Nhwa, Piramal, AbbVie, Baxter Healthcare, Hengrui, Lunan, Mylan

What are the Application segmentation covered in the General Anesthesia Medicine Market report?

Ans: The Applications covered in the General Anesthesia Medicine Market report are Intravenous Anesthetics, Inhalational Anesthetics

What are the Type segmentation covered in the General Anesthesia Medicine Market report?

Ans: The Types covered in the General Anesthesia Medicine Market report are Propofol, Etomidate, Midazolam, Sevoflurane, Isoflurane, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anesthesia Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 Market by Application
1.3.1 Global General Anesthesia Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anesthesia Medicine Market Perspective (2019-2030)
2.2 General Anesthesia Medicine Growth Trends by Region
2.2.1 Global General Anesthesia Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 General Anesthesia Medicine Historic Market Size by Region (2019-2024)
2.2.3 General Anesthesia Medicine Forecasted Market Size by Region (2025-2030)
2.3 General Anesthesia Medicine Market Dynamics
2.3.1 General Anesthesia Medicine Industry Trends
2.3.2 General Anesthesia Medicine Market Drivers
2.3.3 General Anesthesia Medicine Market Challenges
2.3.4 General Anesthesia Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anesthesia Medicine Players by Revenue
3.1.1 Global Top General Anesthesia Medicine Players by Revenue (2019-2024)
3.1.2 Global General Anesthesia Medicine Revenue Market Share by Players (2019-2024)
3.2 Global General Anesthesia Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anesthesia Medicine Revenue
3.4 Global General Anesthesia Medicine Market Concentration Ratio
3.4.1 Global General Anesthesia Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anesthesia Medicine Revenue in 2023
3.5 General Anesthesia Medicine Key Players Head office and Area Served
3.6 Key Players General Anesthesia Medicine Product Solution and Service
3.7 Date of Enter into General Anesthesia Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anesthesia Medicine Breakdown Data by Type
4.1 Global General Anesthesia Medicine Historic Market Size by Type (2019-2024)
4.2 Global General Anesthesia Medicine Forecasted Market Size by Type (2025-2030)
5 General Anesthesia Medicine Breakdown Data by Application
5.1 Global General Anesthesia Medicine Historic Market Size by Application (2019-2024)
5.2 Global General Anesthesia Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America General Anesthesia Medicine Market Size (2019-2030)
6.2 North America General Anesthesia Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America General Anesthesia Medicine Market Size by Country (2019-2024)
6.4 North America General Anesthesia Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anesthesia Medicine Market Size (2019-2030)
7.2 Europe General Anesthesia Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe General Anesthesia Medicine Market Size by Country (2019-2024)
7.4 Europe General Anesthesia Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anesthesia Medicine Market Size (2019-2030)
8.2 Asia-Pacific General Anesthesia Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific General Anesthesia Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific General Anesthesia Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anesthesia Medicine Market Size (2019-2030)
9.2 Latin America General Anesthesia Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America General Anesthesia Medicine Market Size by Country (2019-2024)
9.4 Latin America General Anesthesia Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anesthesia Medicine Market Size (2019-2030)
10.2 Middle East & Africa General Anesthesia Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa General Anesthesia Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa General Anesthesia Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Detail
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca General Anesthesia Medicine Introduction
11.1.4 Astrazeneca Revenue in General Anesthesia Medicine Business (2019-2024)
11.1.5 Astrazeneca Recent Development
11.2 B.Braun
11.2.1 B.Braun Company Detail
11.2.2 B.Braun Business Overview
11.2.3 B.Braun General Anesthesia Medicine Introduction
11.2.4 B.Braun Revenue in General Anesthesia Medicine Business (2019-2024)
11.2.5 B.Braun Recent Development
11.3 Fresenius-Kabi
11.3.1 Fresenius-Kabi Company Detail
11.3.2 Fresenius-Kabi Business Overview
11.3.3 Fresenius-Kabi General Anesthesia Medicine Introduction
11.3.4 Fresenius-Kabi Revenue in General Anesthesia Medicine Business (2019-2024)
11.3.5 Fresenius-Kabi Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Detail
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals General Anesthesia Medicine Introduction
11.4.4 Hikma Pharmaceuticals Revenue in General Anesthesia Medicine Business (2019-2024)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Maruishi
11.5.1 Maruishi Company Detail
11.5.2 Maruishi Business Overview
11.5.3 Maruishi General Anesthesia Medicine Introduction
11.5.4 Maruishi Revenue in General Anesthesia Medicine Business (2019-2024)
11.5.5 Maruishi Recent Development
11.6 Nhwa
11.6.1 Nhwa Company Detail
11.6.2 Nhwa Business Overview
11.6.3 Nhwa General Anesthesia Medicine Introduction
11.6.4 Nhwa Revenue in General Anesthesia Medicine Business (2019-2024)
11.6.5 Nhwa Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal General Anesthesia Medicine Introduction
11.7.4 Piramal Revenue in General Anesthesia Medicine Business (2019-2024)
11.7.5 Piramal Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie General Anesthesia Medicine Introduction
11.8.4 AbbVie Revenue in General Anesthesia Medicine Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Detail
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare General Anesthesia Medicine Introduction
11.9.4 Baxter Healthcare Revenue in General Anesthesia Medicine Business (2019-2024)
11.9.5 Baxter Healthcare Recent Development
11.10 Hengrui
11.10.1 Hengrui Company Detail
11.10.2 Hengrui Business Overview
11.10.3 Hengrui General Anesthesia Medicine Introduction
11.10.4 Hengrui Revenue in General Anesthesia Medicine Business (2019-2024)
11.10.5 Hengrui Recent Development
11.11 Lunan
11.11.1 Lunan Company Detail
11.11.2 Lunan Business Overview
11.11.3 Lunan General Anesthesia Medicine Introduction
11.11.4 Lunan Revenue in General Anesthesia Medicine Business (2019-2024)
11.11.5 Lunan Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan General Anesthesia Medicine Introduction
11.12.4 Mylan Revenue in General Anesthesia Medicine Business (2019-2024)
11.12.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global General Anesthesia Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Propofol
    Table 3. Key Players of Etomidate
    Table 4. Key Players of Midazolam
    Table 5. Key Players of Sevoflurane
    Table 6. Key Players of Isoflurane
    Table 7. Key Players of Others
    Table 8. Global General Anesthesia Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global General Anesthesia Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global General Anesthesia Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global General Anesthesia Medicine Market Share by Region (2019-2024)
    Table 12. Global General Anesthesia Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global General Anesthesia Medicine Market Share by Region (2025-2030)
    Table 14. General Anesthesia Medicine Market Trends
    Table 15. General Anesthesia Medicine Market Drivers
    Table 16. General Anesthesia Medicine Market Challenges
    Table 17. General Anesthesia Medicine Market Restraints
    Table 18. Global General Anesthesia Medicine Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global General Anesthesia Medicine Market Share by Players (2019-2024)
    Table 20. Global Top General Anesthesia Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthesia Medicine as of 2023)
    Table 21. Ranking of Global Top General Anesthesia Medicine Companies by Revenue (US$ Million) in 2023
    Table 22. Global 5 Largest Players Market Share by General Anesthesia Medicine Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players General Anesthesia Medicine Product Solution and Service
    Table 25. Date of Enter into General Anesthesia Medicine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global General Anesthesia Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global General Anesthesia Medicine Revenue Market Share by Type (2019-2024)
    Table 29. Global General Anesthesia Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global General Anesthesia Medicine Revenue Market Share by Type (2025-2030)
    Table 31. Global General Anesthesia Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global General Anesthesia Medicine Revenue Market Share by Application (2019-2024)
    Table 33. Global General Anesthesia Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global General Anesthesia Medicine Revenue Market Share by Application (2025-2030)
    Table 35. North America General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America General Anesthesia Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America General Anesthesia Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Europe General Anesthesia Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 40. Europe General Anesthesia Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Asia-Pacific General Anesthesia Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Asia-Pacific General Anesthesia Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 43. Asia-Pacific General Anesthesia Medicine Market Size by Region (2025-2030) & (US$ Million)
    Table 44. Latin America General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Latin America General Anesthesia Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Latin America General Anesthesia Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Middle East & Africa General Anesthesia Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Middle East & Africa General Anesthesia Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa General Anesthesia Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 50. Astrazeneca Company Detail
    Table 51. Astrazeneca Business Overview
    Table 52. Astrazeneca General Anesthesia Medicine Product
    Table 53. Astrazeneca Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 54. Astrazeneca Recent Development
    Table 55. B.Braun Company Detail
    Table 56. B.Braun Business Overview
    Table 57. B.Braun General Anesthesia Medicine Product
    Table 58. B.Braun Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 59. B.Braun Recent Development
    Table 60. Fresenius-Kabi Company Detail
    Table 61. Fresenius-Kabi Business Overview
    Table 62. Fresenius-Kabi General Anesthesia Medicine Product
    Table 63. Fresenius-Kabi Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 64. Fresenius-Kabi Recent Development
    Table 65. Hikma Pharmaceuticals Company Detail
    Table 66. Hikma Pharmaceuticals Business Overview
    Table 67. Hikma Pharmaceuticals General Anesthesia Medicine Product
    Table 68. Hikma Pharmaceuticals Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 69. Hikma Pharmaceuticals Recent Development
    Table 70. Maruishi Company Detail
    Table 71. Maruishi Business Overview
    Table 72. Maruishi General Anesthesia Medicine Product
    Table 73. Maruishi Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 74. Maruishi Recent Development
    Table 75. Nhwa Company Detail
    Table 76. Nhwa Business Overview
    Table 77. Nhwa General Anesthesia Medicine Product
    Table 78. Nhwa Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 79. Nhwa Recent Development
    Table 80. Piramal Company Detail
    Table 81. Piramal Business Overview
    Table 82. Piramal General Anesthesia Medicine Product
    Table 83. Piramal Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 84. Piramal Recent Development
    Table 85. AbbVie Company Detail
    Table 86. AbbVie Business Overview
    Table 87. AbbVie General Anesthesia Medicine Product
    Table 88. AbbVie Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 89. AbbVie Recent Development
    Table 90. Baxter Healthcare Company Detail
    Table 91. Baxter Healthcare Business Overview
    Table 92. Baxter Healthcare General Anesthesia Medicine Product
    Table 93. Baxter Healthcare Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 94. Baxter Healthcare Recent Development
    Table 95. Hengrui Company Detail
    Table 96. Hengrui Business Overview
    Table 97. Hengrui General Anesthesia Medicine Product
    Table 98. Hengrui Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 99. Hengrui Recent Development
    Table 100. Lunan Company Detail
    Table 101. Lunan Business Overview
    Table 102. Lunan General Anesthesia Medicine Product
    Table 103. Lunan Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 104. Lunan Recent Development
    Table 105. Mylan Company Detail
    Table 106. Mylan Business Overview
    Table 107. Mylan General Anesthesia Medicine Product
    Table 108. Mylan Revenue in General Anesthesia Medicine Business (2019-2024) & (US$ Million)
    Table 109. Mylan Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global General Anesthesia Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global General Anesthesia Medicine Market Share by Type: 2023 VS 2030
    Figure 3. Propofol Features
    Figure 4. Etomidate Features
    Figure 5. Midazolam Features
    Figure 6. Sevoflurane Features
    Figure 7. Isoflurane Features
    Figure 8. Others Features
    Figure 9. Global General Anesthesia Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global General Anesthesia Medicine Market Share by Application: 2023 VS 2030
    Figure 11. Intravenous Anesthetics Case Studies
    Figure 12. Inhalational Anesthetics Case Studies
    Figure 13. General Anesthesia Medicine Report Years Considered
    Figure 14. Global General Anesthesia Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global General Anesthesia Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global General Anesthesia Medicine Market Share by Region: 2023 VS 2030
    Figure 17. Global General Anesthesia Medicine Market Share by Players in 2023
    Figure 18. Global Top General Anesthesia Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthesia Medicine as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by General Anesthesia Medicine Revenue in 2023
    Figure 20. North America General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America General Anesthesia Medicine Market Share by Country (2019-2030)
    Figure 22. United States General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe General Anesthesia Medicine Market Share by Country (2019-2030)
    Figure 26. Germany General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific General Anesthesia Medicine Market Share by Region (2019-2030)
    Figure 34. China General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America General Anesthesia Medicine Market Share by Country (2019-2030)
    Figure 42. Mexico General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa General Anesthesia Medicine Market Share by Country (2019-2030)
    Figure 46. Turkey General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia General Anesthesia Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Astrazeneca Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 49. B.Braun Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 50. Fresenius-Kabi Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 51. Hikma Pharmaceuticals Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 52. Maruishi Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 53. Nhwa Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 54. Piramal Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 55. AbbVie Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 56. Baxter Healthcare Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 57. Hengrui Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 58. Lunan Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 59. Mylan Revenue Growth Rate in General Anesthesia Medicine Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Immune Thrombocytopenia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-24G3922
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Muscle Relaxants Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28K7363
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Intrathecal Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0G14265
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Drugs for Short Bowel Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19D6153
Tue Oct 08 00:00:00 UTC 2024

Add to Cart